Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis

Abstract

Hepatitis C virus (HCV) causes a persistent infection, chronic hepatitis and hepatocellular carcinoma. HCV NS5A, one of non-structural proteins of HCV, was suggested to play a role in oncogenic transformation. Since the tumor suppressor p53 is important for preventing neoplastic transformation, we investigated the functional effects of HCV NS5A on p53. In vitro and in vivo coimmunoprecipitation and confocal microscopy were used to determine the interaction of NS5A and p53. HCV NS5A binds directly to p53 and colocalizes p53 in the perinuclear region. NS5A inhibits transcriptional transactivation by p53 in a dose-dependent manner by use of a reporter assay. Down regulation of endogenous p21/waf1 expression, which is activated by p53 in Hep3B cells, by NS5A was demonstrated by using FLAG- and FLAG-NS5A Hep3B stable cell lines. The effect of NS5A on p53-mediated apoptosis was determined by flow cytometry in both NS5A permanently and transiently transfected Hep3B cells with exogenous p53. The p53-induced apoptosis was abrogated by NS5A and the inhibition effect correlates well with the binding ability of NS5A to p53. In addition, HCV NS5A protein interacts with and colocalizes hTAFII32, a component of TFIID and an essential coactivator of p53, in vivo. These results suggest that HCV NS5A interacts with and partially sequestrates p53 and hTAFII32 in the cytoplasm and suppresses p53-mediated transcriptional transactivation and apoptosis during HCV infection, which may contribute to the hepatocarcinogenesis of HCV infection.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Chen X, Ko LJ, Jayaraman L, Prives C . 1996 Genes Dev. 10: 2438–2451

  • Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina-Selby R, Barr PJ, Weiner AJ, Bradley D, Kuo G, Houghton M . 1991 Proc. Natl. Acad. Sci. USA 88: 2451–2455

  • Chung KM, Song OK, Jang SK . 1997 Mol. Cell. 7: 661–667

  • Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH . 1993 Nature 362: 849–852

  • Dobner T, Horikoshi N, Rubenwolf S, Shenk T . 1996 Science 272: 1470–1473

  • Dyson N, Howley PM, Munger K, Harlow E . 1989 Science 243: 934–937

  • Eliyahu D, Michalovitz D, Eliyahu S, Pinhasi-Kimhi O, Oren M . 1989 Proc. Natl. Acad. Sci. USA 86: 8763–8767

  • Elmore LW, Hancock AR, Chang SF, Wang XW, Chang S, Callahan CP, Geller DA, Will H, Harris CC . 1997 Proc. Natl. Acad. Sci. USA 94: 14707–14712

  • Finlay CA, Hinds PW, Levine AJ . 1989 Cell 57: 1083–1093

  • Fukuma T, Enomoto N, Marumo F, Sato C . 1998 Hepatology 28: 1147–1153

  • Gale Jr M, Kwieciszewski B, Dossett M, Nakao H, Katze MG . 1999 J. Virol. 73: 6506–6516

  • Ghosh AK, Steele R, Meyer K, Ray R, Ray RB . 1999 J. Gen. Virol. 80: 1179–1183

  • Grakoui A, Wychowski C, Lin C, Feinstone SM, Rice CM . 1993 J. Virol. 67: 1385–1395

  • Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Shimotohno K . 1991 Proc. Natl. Acad. Sci. USA 88: 5547–5551

  • Houghton M . 1996 Fields Virology Fields BN, DMK, Howley PM, Chanock RM, Melnick JL, Monath TP, Roizman B and Straus SE (eds) Philadelphia: Lippincott-Raven Publishers pp 1035–1058

    Google Scholar 

  • Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC . 1991 Nature 350: 427–428

  • Ide Y, Zhang L, Chen M, Inchauspe G, Bahl C, Sasaguri Y, Padmanabhan R . 1996 Gene 182: 203–211

  • Ingles CJ, Shales M, Cress WD, Triezenberg SJ, Greenblatt J . 1991 Nature 351: 588–590

  • Kaneko T, Tanji Y, Satoh S, Hijikata M, Asabe S, Kimura K, Shimotohno K . 1994 Biochem. Biophys. Res. Commun. 205: 320–326

  • Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugimura T, Shimotohno K . 1990 Proc. Natl. Acad. Sci. USA 87: 9524–9528

  • Kato N, Lan KH, Ono-Nita SK, Shiratori Y, Omata M . 1997 J. Virol. 71: 8856–8859

  • Ko LJ, Prives C . 1996 Genes Dev. 10: 1054–1072

  • Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee WS, Kuo C, Berger K, Shuster JR, Overby LR, Bradley DW, Houghton M . 1989 Science 244: 362–364

  • Lane DP . 1992 Nature 358: 15–16

  • Lane DP, Crawford LV . 1979 Nature 278: 261–263

  • Levine AJ . 1993 Annu. Rev. Biochem. 62: 623–651

  • Levine AJ . 1997 Cell 88: 323–331

  • Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R . 1999 Science 285: 110–113

  • Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T . 1994 Science 266: 807–810

  • Lowe SW, Ruley HE, Jacks T, Housman DE . 1993a Cell 74: 957–967

  • Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T . 1993b Nature 362: 847–849

  • Lu H, Levine AJ . 1995 Proc. Natl. Acad. Sci. USA 92: 5154–5158

  • Lu W, Lo SY, Chen M, Wu K, Fung YK, Ou JH . 1999 Virology 264: 134–141

  • Majumder M, Ghosh AK, Steele R, Ray R, Ray RB . 2001 J. Virol. 75: 1401–1407

  • Moradpour D, Kary P, Rice CM, Blum HE . 1998 Hepatology 28: 192–201

  • Mulloy JC, Kislyakova T, Cereseto A, Casareto L, LoMonico A, Fullen J, Lorenzi MV, Cara A, Nicot C, Giam C, Franchini G . 1998 J. Virol. 72: 8852–8860

  • Muralidhar S, Doniger J, Mendelson E, Araujo JC, Kashanchi F, Azumi N, Brady JN, Rosenthal LJ . 1996 J. Virol. 70: 8691–8700

  • Neil JC, Cameron ER, Baxter EW . 1997 Trends Microbiol. 5: 115–120

  • Niwa H, Yamamura K, Miyazaki J . 1991 Gene 108: 193–199

  • Ohashi M, Kanai F, Ueno H, Tanaka T, Tateishi K, Kawakami T, Koike Y, Ikenoue T, Shiratori Y, Hamada H, Omata M . 1999 Gut 44: 366–371

  • Otsuka M, Kato N, Lan KH, Yoshida H, Kato J, Goto T, Shiratori Y, Omata M . 2000 J. Biol. Chem. 275: 34122–34130

  • Pise-Masison CA, Choi KS, Radonovich M, Dittmer J, Kim SJ, Brady JN . 1998 J. Virol. 72: 1165–1170

  • Polyak SJ, Paschal DM, McArdle S, Gale Jr MJ, Moradpour D, Gretch DR . 1999 Hepatology 29: 1262–1271

  • Prost S, Ford JM, Taylor C, Doig J, Harrison DJ . 1998 J. Biol. Chem. 273: 33327–33332

  • Ray RB, Steele R, Meyer K, Ray R . 1997 J. Biol. Chem. 272: 10983–10986

  • Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y, Choo Q, Houghton M, Kuo G . 1990 Proc. Natl. Acad. Sci. USA 87: 6547–6549

  • Sarnow P, Ho YS, Williams J, Levine AJ . 1982 Cell 28: 387–394

  • Satoh S, Hirota M, Noguchi T, Hijikata M, Handa H, Shimotohno K . 2000 Virology 270: 476–487

  • Scheffner M, Takahashi T, Huibregtse JM, Minna JD, Howley PM . 1992 J. Virol. 66: 5100–5105

  • Shaulsky G, Goldfinger N, Tosky MS, Levine AJ, Rotter V . 1991 Oncogene 6: 2055–2065

  • Sheppard HM, Corneillie SI, Espiritu C, Gatti A, Liu X . 1999 Mol. Cell. Biol. 19: 2746–2753

  • Shieh YS, Nguyen C, Vocal MV, Chu HW . 1993 Int. J. Cancer 54: 558–562

  • Shiratori Y, Shiina S, Imamura M, Kato N, Kanai F, Okudaira T, Teratani T, Tohgo G, Toda N, Ohashi M, Ogura K, Niwa Y, Kawabe T, Omata M . 1995 Hepatology 22: 1027–1033

  • Stringer KF, Ingles CJ, Greenblatt J . 1990 Nature 345: 783–786

  • Symonds H, Krall L, Remington L, Saenz-Robles M, Lowe S, Jacks T, Van Dyke T . 1994 Cell 78: 703–711

  • Takada S, Kaneniwa N, Tsuchida N, Koike K . 1997 Oncogene 15: 1895–1901

  • Tanimoto A, Ide Y, Arima N, Sasaguri Y, Padmanabhan R . 1997 Biochem. Biophys. Res. Commun. 236: 360–364

  • Thompson CB . 1995 Science 267: 1456–1462

  • Thut CJ, Chen JL, Klemm R, Tjian R . 1995 Science 267: 100–104

  • Uchida T, Takahashi K, Tatsuno K, Dhingra U, Eliason JF . 1996 Int. J. Cancer 67: 892–897

  • Ueda H, Ullrich SJ, Gangemi JD, Kappel CA, Ngo L, Feitelson MA, Jay G . 1995 Nat. Genet. 9: 41–47

  • Uesugi M, Nyanguile O, Lu H, Levine AJ, Verdine GL . 1997 Science 277: 1310–1313

  • Wang XW, Forrester K, Yeh H, Feitelson MA, Gu JR, Harris CC . 1994 Proc. Natl. Acad. Sci. USA 91: 2230–2234

  • Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester K, Sturzbecher HW, Hoeijmakers JH, Harris CC . 1995 Cancer Res. 55: 6012–6016

  • Zantema A, Fransen JA, Davis-Olivier A, Ramaekers FC, Vooijs GP, DeLeys B, van der Eb A . 1985a Virology 142: 44–58

  • Zantema A, Schrier PI, Davis-Olivier A, van Laar T, Vaessen RT, van der Eb A . 1985b Mol. Cell. Biol. 5: 3084–3091

Download references

Acknowledgements

We thank Junichi Miyazaki, Yan-Hwa Wu Lee, Robert Tijin for their gifts of plasmids and Xin Wei Wang (NCI, NIH, USA) for reviewing this manuscript. The study was partially supported by grants from the National Science Council, Taiwan (NSC 89-2315-B-075-002 and NSC 90-2314-B-075-037-MH).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shou-Dong Lee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lan, KH., Sheu, ML., Hwang, SJ. et al. HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis. Oncogene 21, 4801–4811 (2002). https://doi.org/10.1038/sj.onc.1205589

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205589

Keywords

This article is cited by

Search

Quick links